Mercy A. Okezue
Materials Science · Purdue University West Lafayette
Publications
28
Citations
96
Est. group size
~2
Recurring co-author estimate
Active years
8
Publishing since 2019
Mercy A. Okezue's work focuses on pharmaceutical materials science, particularly the chemistry, crystal structure, and formulation of drugs such as bedaquiline (a tuberculosis medication) and levothyroxine. Her research includes creating different salt forms of drugs to improve solubility, determining crystal structures using X-ray diffraction, and designing nanoparticle-based drug delivery systems. She also contributes to work on laboratory quality management systems and accreditation in healthcare settings, particularly in African contexts.
Publication output has been variable but generally active over the last decade, rising from no recorded output in 2017-2018 to a peak of 7 publications in 2024, with an average of about 3.4 publications per year over the last five years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Peer Review Report For: Implementing and Transitioning a Laboratory Quality Management System from ISO 15189:2012 to ISO 15189:2022: Experience from the Malawi-Liverpool Wellcome Research Programme, Blantyre [version 1; peer review: 1 approved with reservations]
2026
- Peer Review Report For: Implementing and Transitioning a Laboratory Quality Management System from ISO 15189:2012 to ISO 15189:2022: Experience from the Malawi-Liverpool Wellcome Research Programme, Blantyre [version 2; peer review: 1 approved, 1 approved with reservations]
2026
- Medical Laboratories in Healthcare Delivery: A Systematic Review of Their Roles and Impact
Laboratories · 2025
- A Quality by Design Approach for Optimizing Solid Lipid Nanoparticles of Bedaquiline for Improved Product Performance
AAPS PharmSciTech · 2024
- Model Adequacy in Assessing the Predictive Performance of Regression Models in Pharmaceutical Product Optimization: The Bedaquiline Solid Lipid Nanoparticle Example
Scientia Pharmaceutica · 2024
- Transfer learning predicts species-specific drug interactions in emerging pathogens
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- The safety, quality evaluation, and lot release of COVID-19 vaccines imported and used in Nigeria from march 2021 to march 2022
Discover Health Systems · 2024
- Model Adequacy in Assessing the Predictive Performance of Regression Models in Pharmaceutical Product Optimization: The Bedaquiline Solid Lipid Nanoparticle Example
Preprints.org · 2024
- Potency and Powder X-ray Diffraction (PXRD) Evaluation of Levothyroxine Sodium Tablets under Ambient, Accelerated, and Stressed Conditions
Pharmaceuticals · 2023
- Synthesis, Characterization, and Stability Assessment for the Benzoate, Hydrochloride, Malonate, and Nicotinate Salts of Bedaquiline
Pharmaceuticals · 2023
- Determining the solubilities for benzoate, nicotinate, hydrochloride, and malonate salts of bedaquiline
International Journal of Pharmaceutics · 2022
- CCDC 2179234: Experimental Crystal Structure Determination
The Cambridge Structural Database · 2022
- CCDC 2179236: Experimental Crystal Structure Determination
The Cambridge Structural Database · 2022
- CCDC 2179235: Experimental Crystal Structure Determination
The Cambridge Structural Database · 2022
- CCDC 2072584: Experimental Crystal Structure Determination
The Cambridge Structural Database · 2021
- The Cambridge Structural Database×8
- AAPS PharmSciTech×2
- Pharmaceuticals×2
- The Proceedings of the BIRS Community×2
- BMC Health Services Research×1
- Tonglei Li
Materials Science · Purdue University West Lafayette
- Geoff G. Z. Zhang
Materials Science · Purdue University West Lafayette
- Changquan Calvin Sun
Materials Science · Purdue University West Lafayette
- Na Li
Materials Science · Purdue University West Lafayette
- Stephen R. Byrn
Materials Science · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile